The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis

神经保护 药理学 医学 纤溶酶原激活剂 组织纤溶酶原激活剂 缺血 HIF1A型 脑缺血 冲程(发动机) 血管生成 内科学 工程类 机械工程
作者
Thorsten R. Doeppner,Izabela Młynarczuk-Biały,Ulrike Kuckelkorn,Britta Kaltwasser,Josephine Herz,Mohammad R. Hasan,Dirk M. Hermann,Mathias Bähr
出处
期刊:Brain [Oxford University Press]
卷期号:135 (11): 3282-3297 被引量:66
标识
DOI:10.1093/brain/aws269
摘要

Only a minority of stroke patients receive thrombolytic therapy. Therefore, new therapeutic strategies focusing on neuroprotection are under review, among which, inhibition of the proteasome is attractive, as it affects multiple cellular pathways. As proteasome inhibitors like bortezomib have severe side effects, we applied the novel proteasome inhibitor BSc2118, which is putatively better tolerated, and analysed its therapeutic potential in a mouse model of cerebral ischaemia. Stroke was induced in male C57BL/6 mice using the intraluminal middle cerebral artery occlusion model. BSc2118 was intrastriatally injected 12 h post-stroke in mice that had received normal saline or recombinant tissue-plasminogen activator injections during early reperfusion. Brain injury, behavioural tests, western blotting, MMP9 zymography and analysis of angioneurogenesis were performed for up to 3 months post-stroke. Single injections of BSc2118 induced long-term neuroprotection, reduced functional impairment, stabilized blood-brain barrier through decreased MMP9 activity and enhanced angioneurogenesis when given no later than 12 h post-stroke. On the contrary, recombinant tissue-plasminogen activator enhanced brain injury, which was reversed by BSc2118. Protein expression of the transcription factor HIF1A was significantly increased in saline-treated and recombinant tissue-plasminogen activator-treated mice after BSc2118 application. In contrast, knock-down of HIF1A using small interfering RNA constructs or application of the HIF1A inhibitor YC1 (now known as RNA-binding motif, single-stranded-interacting protein 1 (RBMS1)) reversed BSc2118-induced neuroprotection. Noteworthy, loss of neuroprotection after combined treatment with BSc2118 and YC1 in recombinant tissue-plasminogen activator-treated animals was in the same order as in saline-treated mice, i.e. reduction of recombinant tissue-plasminogen activator toxicity through BSc2118 did not solely depend on HIF1A. Thus, the proteasome inhibitor BSc2118 is a promising new candidate for stroke therapy, which may in addition alleviate recombinant tissue-plasminogen activator-induced brain toxicity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
3秒前
3秒前
温山先生发布了新的文献求助10
3秒前
4秒前
安稳的乐松完成签到,获得积分20
4秒前
默默发布了新的文献求助10
5秒前
6秒前
Anita完成签到,获得积分20
7秒前
7秒前
粗心的从露完成签到,获得积分10
8秒前
乔治发布了新的文献求助10
8秒前
bkagyin的应助被冬至采纳,获得10
9秒前
lilili发布了新的文献求助10
9秒前
9秒前
Hello的应助被华熙采纳,获得40
9秒前
一枝清荷发布了新的文献求助10
10秒前
10秒前
yyds的应助被鱼籽派采纳,获得10
11秒前
高大的柜子完成签到 ,获得积分10
11秒前
syvshc的应助被jessie采纳,获得10
11秒前
moshang完成签到 ,获得积分10
12秒前
12秒前
xfy发布了新的文献求助200
12秒前
13秒前
14秒前
香蕉觅云的应助被Liu采纳,获得10
14秒前
huoyunli发布了新的文献求助10
14秒前
yuan完成签到,获得积分20
15秒前
彦页关注了科研通微信公众号
15秒前
含糊的剑封完成签到,获得积分10
15秒前
Sunny完成签到,获得积分10
15秒前
li完成签到 ,获得积分10
16秒前
16秒前
汉堡包的应助被顺利采纳,获得10
16秒前
兰州2026完成签到 ,获得积分10
17秒前
17秒前
yyy完成签到,获得积分10
18秒前
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193514
求助须知:如何正确求助?哪些是违规求助? 9579686
关于积分的说明 21866883
捐赠科研通 7793152
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484176